Mesoblast Draws US$50 Million from Five-Year Non-Dilutive Facility
Mesoblast Limited announced a $50 million drawdown from a new five-year credit facility at a fixed 8% interest rate, replacing higher cost short-term debt. The financing is secured solely by Temcell royalty and enables the company to strengthen its balance sheet without encumbering material assets or intellectual property. With $122 million cash on…